NUTANIX INC - A (NTNX) Stock Analyst Ratings
USA - NASDAQ:NTNX - US67059N1081 - Common Stock
69.62 USD
+0.82 (+1.19%)
70.9933 USD
+1.37 (+1.97%)
ChartMill assigns a Buy % Consensus number of 82% to NTNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 89.32. This target is 28.3% above the current price.
NTNX was analyzed by 25 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NTNX.
In the previous month the buy percentage consensus was at a similar level.
NTNX was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-28 | Needham | Maintains | Buy -> Buy |
| 2025-08-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-15 | Goldman Sachs | Initiate | Buy |
| 2025-06-26 | Keybanc | Initiate | Overweight |
| 2025-05-29 | Needham | Reiterate | Buy -> Buy |
| 2025-05-29 | Susquehanna | Maintains | Positive -> Positive |
| 2025-05-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-20 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-05-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-27 | UBS | Maintains | Buy -> Buy |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-27 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-17 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-12 | UBS | Initiate | Buy |
| 2024-11-27 | Needham | Maintains | Buy -> Buy |
| 2024-11-27 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-27 | Northland Capital Markets | Reiterate | Market Perform -> Market Perform |
NUTANIX INC - A / NTNX FAQ
What is the price target for NTNX stock?
25 analysts have analysed NTNX and the average price target is 89.32 USD. This implies a price increase of 28.3% is expected in the next year compared to the current price of 69.62.
Can you provide the consensus rating for NUTANIX INC - A stock?
The consensus rating for NUTANIX INC - A (NTNX) is 81.6 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NUTANIX INC - A (NTNX)?
The number of analysts covering NUTANIX INC - A (NTNX) is 25.